Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CRL Charles River > Detailed Quotes

CRL Charles River

187.510
+2.680+1.45%
Close 09/23 16:00 ET
187.5100.0000.00%
Post Mkt Price 09/23 16:03 ET
High
188.080
Open
183.310
Turnover
147.98M
Low
182.020
Pre Close
184.830
Volume
800.55K
Market Cap
9.54B
P/E(TTM)
21.78
52wk High
449.340
Shares
50.86M
P/E(Static)
24.67
52wk Low
182.020
Float Cap
9.42B
Bid/Ask %
0.00%
Historical High
460.210
Shs Float
50.25M
Volume Ratio
1.38
Historical Low
17.188
Dividend TTM
--
Div Yield TTM
2500
P/B
3.60
Dividend LFY
--
Div Yield LFY
1333.26%
Turnover Ratio
1.59%
Amplitude
3.28%
Avg Price
184.844
Lot Size
1
Float Cap
9.42B
Bid/Ask %
0.00%
Historical High
460.210
Shs Float
50.25M
Volume Ratio
1.38
Historical Low
17.188
Dividend TTM
--
P/B
3.60
Dividend LFY
--
Turnover Ratio
1.59%
Amplitude
3.28%
Avg Price
184.844
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides research models required in the research and development of new drugs, devices, and therapies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment consists of the commercial production and sale of research models, research products, and the provision of services related to the maintenance and monitoring of research models and the management of the clients’ research operations. The Discovery and Safety Assessment segment offers integrated drug discovery services directed at the identification, screening, and selection of a lead compound for drug development and offers safety assessment services, including bioanalysis, drug metabolism, pharmacokinetics, toxicology, and pathology. The Manufacturing Support segment consists of Microbial Solutions, which provides in vitro (non-animal) lot-release testing products, microbial detection products, and species identification services, Biologics Solutions, which performs specialized testing of biologics as well as contract development and manufacturing, and Avian Vaccine Services, which supplies specific-pathogen-free chicken eggs and chickens. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
CEO: Mr. James C. Foster
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...